In the last ten years a number of clinical and behavioral studies of these new technologies were conducted in many southern countries where after the conclusion of some Post Exposure Prophilaxis (PeP) the new technology was incorporated in the national HIV prevention guidelines. However the level of information about that strategy is very low, and the public debate on that matter is still incipient. Peru and South Africa are also implementing prevention programs including PEP or “test and treat” strategies and other countries from the global South have also hosted acceptability and efficacy studies of a range new technologies, including circumcision, microbicides, and home testing. In some cases, they are also being included in official policy guidelines for prevention. These new technologies and strategies achieved great visibility in the 2012 International Conference on AIDS in Washington, D.C.
There are significant gap between the positive conclusion of studies and the effective access to new technologies by those in need, in the large majority of countries, including in Brazil where extensive clinical trials have been conducted. The GAPW believes that we need a critical to ground consistent advocacy work and community mobilization in the new prevention technologies. We consider all those new trends in preventions can be a unique opportunity to establish a global debate about the cultural, legal and ethical implications of the new technologies and strategies on prevention.